InfaCare Pharmaceuticals is an emerging specialty pharmaceutical company founded in 2001. The company focuses on the development and commercialization of proprietary pharmaceuticals for the neonatal and pediatric patient population. In July 2015, the company received a Venture - Series Unknown investment, signaling confidence from investors in its potential for growth and innovation. With a focus on Biotechnology, Health Care, and Pharmaceutical industries, InfaCare Pharmaceuticals is positioned to make a significant impact in the field of pediatric medicine. Although specific details about the investors behind the last investment are unavailable, this injection of funds can potentially drive the company's research and development efforts, further establishing its foothold in the market.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture - Series Unknown | Unknown | - | 08 Jul 2015 | |
Venture - Series Unknown | Unknown | - | 09 Dec 2014 | |
Venture - Series Unknown | Unknown | - | 15 Oct 2014 | |
Series C | Unknown | - | 20 Mar 2013 | |
Series B | Unknown | - | 28 Oct 2008 |
No recent news or press coverage available for InfaCare Pharmaceuticals.